Skip to main content
. 2012 Sep;21(125):175–185. doi: 10.1183/09059180.00003212

Table 2. Treatment regimens for the TREXA study.

Group Subjects n Regular therapy Exacerbation therapy
1 71 BDP 50 μg twice a day BDP 100 μg/β2-rescue
2 72 Placebo BDP 100 μg/β2-rescue
3 71 BDP 50 μg twice a day Placebo/β2-rescue
4 74 Placebo Placebo/β2-rescue

TREXA: TReating Children to Prevent Exacerbations of Asthma; BDP: beclomethasone diproprionate.